Serum activity of indoleamine 2,3-dioxygenase predicts prognosis of community-acquired pneumonia

Journal of Infection

Volumn 63, Issue 3, 2011, Pages 215-222

  Suzuki, Yuzo ^a   Suda, Takafumi ^a   Yokomura, Koushi ^b   Suzuki, Masako ^a   Fujie, Michio ^a   Furuhashi, Kazuki ^a   Hahimoto, Dai ^a   Enomto, Noriyuki ^a   Fujisawa, Tomoyuki ^a   Nakamura, Yutaro ^a   Inui, Naoki ^a   Nakano, Yutaka ^b   Nakamura, Hirotoshi ^a   Chida, Kingo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SEIREI MIKATAHARA GENERAL HOSPITAL   (Japan)

Author keywords

Community acquired pneumonia; Indoleamine 2,3 dioxygenase; Kynurenine; Tryptophan

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; LACTATE DEHYDROGENASE; NITROGEN; TRYPTOPHAN; UREA;

ACINETOBACTER BAUMANNII; ADULT; AGED; ARTICLE; BLOOD CULTURE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KLEBSIELLA PNEUMONIAE; LEGIONELLA PNEUMOPHILA; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA SEVERITY INDEX; PREDICTION; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY FAILURE; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTE COUNT; TRYPTOPHAN METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; KYNURENINE; MALE; MIDDLE AGED; PNEUMONIA; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TRYPTOPHAN; YOUNG ADULT;

EID: 80052259078     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.07.003     Document Type: Article

References (30)

1. Munn D.H., Mellor A.L. Indoleamine 2,3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007, 117:1147-1154.
2. Katz J.B., Muller A.J., Prendergast G.C. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 2008, 222:206-221.
3. Uyttenhove C., Pilotte L., Théate I., Stroobant V., Colau D., Parmentier N., et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003, 9:1269-1274.
4. Mellor A.L., Munn D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004, 4:762-774.
5. Zelante T., Fallarino F., Bistoni F., Puccetti P., Romani L. Indoleamine 2,3 dioxygenase in infection: the paradox of an evasive strategy that benefits the host. Microbes Infect 2009, 11:133-141.
6. Munn D.H., Schafizadeh E., Attwood J.T., Bonarev I., Pashine A., Mellor A.L. Inhibitation of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999, 189:1363-1372.
7. Schroecksnadel K., Wirleitner B., Winkler C., Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006, 364:82-90.
8. Munn D.H., Zhou M., Attwood J.T., Bondarev I., Conway S.J., Marshall B., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998, 281:1191-1193.
9. Aluvihare V.R., Kallikourdis M., Betz A.G. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004, 5:266-271.
10. Jasperson L.K., Bucher C., Panoskaltsis-Mortari A., Taylor P.A., Mellor A.L., Munn D.H., et al. Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality. Blood 2008, 111:3257-3265.
11. Jasperson L.K., Bucher C., Panoskaltsis-Mortari A., Mellor A.L., Munn D.H., Blazar B.R. Inducing the tryptophan catabolic pathway. Indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood 2009, 114:5062-5070.
12. Widner B., Sepp N., Kowald E., Ortner U., Wirleitner B., Fritsch P., et al. Enhanced tryptophan degradation in systemic lupus erythematosus. Immunobiology 2000, 201:621-630.
13. Schroecksnadel K., Kaser S., Ledochowski M., Neurauter G., Mur E., Herold M., et al. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J Rheumatol 2003, 30:1935-1939.
14. Huttunen R., Syrjänen J., Aittoniemi J., Oja S.S., Raitala A., Laine J., et al. High activity of indoleamine 2,3-dioxygenase enzyme predicts disease severity and case fatality in bacteremic patients. Shock 2010, 33:149-154.
15. Jung I.D., Lee M.G., Chang J.H., Lee J.S., Jeong Y.I., Lee C.M., et al. Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock. J Immunol 2009, 182:3146-3154.
16. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
17. Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
18. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31:1250-1256.
19. Suzuki Y., Suda T., Furuhashi K., Suzuki M., Fujie M., Hashimoto D., et al. Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer. Lung Cancer 2010, 67:361-365.
20. Ino K., Yoshida N., Kajiyama H., Shibata K., Yamamoto E., Kidokoro K., et al. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer. Br J Cancer 2006, 95:1555-1561.
21. Brandacher G., Perathoner A., Ladurner R., Schneeberger S., Obrist P., Winkler C., et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 2006, 12:1144-1151.
22. Okamoto A., Nikaido T., Ochiai K., Takakura S., Saito M., Aoki Y., et al. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells. Clin Cancer Res 2005, 11:6030-6039.
23. Murr C., Gerlach D., Widner B., Dierich M.P., Fuchs D. Neopterin production and tryptophan degradation in human infected by Streptococcus pyogenes. Med Microbiol Immunol 2001, 189:161-163.
24. Huengsberg M., Winer J.B., Gompels M., Round R., Ross J., Shahmanesh M. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients. Clin Chem 1998, 44:858-862.
25. Gasse T., Murr C., Meyersbach P., Schmutzhard E., Wachter H., Fuchs D. Neopterin production and tryptophan degradation in acute Lyme neuroborreliosis versus late Lyme encephalopathy. Eur J Clin Chem Clin Biochem 1994, 32:685-689.
26. Tattevin P., Monnier D., Tribut O., Dulong J., Bescher N., Mourcin F., et al. Enhanced indoleamine 2,3-dioxygenase activity in patients with severe sepsis and septic shock. J Infect Dis 2010, 201:956-966.
27. Müller A., Heseler K., Schmidt S.K., Spekker K., Mackenzie C.R., Däubener W. The missing link between indoleamine 2,3 dioxygenase mediated antibacterial and immunoregulatory effects. J Cell Mol Med 2009, 13:1125-1135.
28. Bozza S., Fallarino F., Pitzurra L., Zelante T., Montagnoli C., Bellocchio S., et al. A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol 2005, 174:2910-2918.
29. Wang Y., Liu H., McKenzie G., Witting P.K., Stasch J.P., Hahn M., et al. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 2010, 16:279-285.
30. Boasso A., Vaccari M., Fuchs D., Hardv A.W., Tsai W.P., Trvniszewska E., et al. Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques. J Immunol 2009, 182:4313-4320.